TD Private Client Wealth LLC Reduces Stock Holdings in Avantor, Inc. $AVTR

TD Private Client Wealth LLC lowered its position in Avantor, Inc. (NYSE:AVTR) by 11.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,315 shares of the company’s stock after selling 913 shares during the quarter. TD Private Client Wealth LLC’s holdings in Avantor were worth $98,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Dodge & Cox grew its holdings in shares of Avantor by 1.1% in the first quarter. Dodge & Cox now owns 100,262,723 shares of the company’s stock valued at $1,625,259,000 after purchasing an additional 1,116,953 shares during the period. Vanguard Group Inc. grew its holdings in shares of Avantor by 1.5% in the first quarter. Vanguard Group Inc. now owns 64,952,926 shares of the company’s stock valued at $1,052,887,000 after purchasing an additional 983,172 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in shares of Avantor by 1.5% in the first quarter. T. Rowe Price Investment Management Inc. now owns 41,969,199 shares of the company’s stock valued at $680,321,000 after purchasing an additional 608,806 shares during the period. 1832 Asset Management L.P. grew its holdings in shares of Avantor by 89.8% in the first quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock valued at $293,842,000 after purchasing an additional 8,578,493 shares during the period. Finally, The Manufacturers Life Insurance Company grew its holdings in shares of Avantor by 53.2% in the first quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock valued at $227,502,000 after purchasing an additional 4,876,524 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AVTR. Morgan Stanley decreased their target price on shares of Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. decreased their target price on shares of Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Stifel Nicolaus set a $12.00 target price on shares of Avantor and gave the company a “hold” rating in a research report on Monday, August 4th. Evercore ISI decreased their target price on shares of Avantor from $18.00 to $16.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Finally, Raymond James Financial set a $14.00 target price on shares of Avantor and gave the company an “outperform” rating in a research report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $15.50.

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 3,476 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the transaction, the chief accounting officer directly owned 55,068 shares in the company, valued at $627,224.52. This represents a 5.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.20% of the stock is owned by corporate insiders.

Avantor Stock Down 0.1%

Shares of NYSE:AVTR opened at $11.83 on Tuesday. The firm’s 50 day moving average price is $12.77 and its 200 day moving average price is $13.57. The stock has a market cap of $8.06 billion, a price-to-earnings ratio of 11.95, a price-to-earnings-growth ratio of 3.81 and a beta of 0.98. Avantor, Inc. has a fifty-two week low of $10.82 and a fifty-two week high of $26.14. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Avantor had a net margin of 10.31% and a return on equity of 11.39%. The firm’s revenue was down 1.1% compared to the same quarter last year. During the same period last year, the business earned $0.25 EPS. As a group, equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.